Toronto, Ontario--(Newsfile Corp. - August 1, 2023) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce that it has paid its second quarterly dividend on its Class A Series 1, 8% Cumulative Redeemable Convertible Non-Voting Preferred Shares (the "A-1 Preferred Shares").

The dividend is $0.02 per share and is payable to the shareholders of record of the A-1 Preferred Shares as of June 30, 2023. Both the Q1 and Q2 dividends have been paid.

The next quarterly dividend is expected to be $0.03 per share, consistent with the recently announced change in the A-1 Preferred dividend rate to 12%, as announced in the press release dated July 14, 2023.

The Company is currently offering additional A-1 Preferred Shares, as announced in its press release dated July 14, 2023.

"We are excited to deliver strong returns to our investors through the A-1 Preferred Offering, fostering an environment of value for our shareholders, while also empowering us to accelerate the expansion of JUMP's revenues," said Mitch Geisler, CEO.

Preferred Shares Outstanding

The Company can confirm that the number of A-1 Preferred Shares currently outstanding is 139,000. On March 31, 2023, 25,000 Preferred Shares were converted into 62,500 common shares at the rate of $0.40 per common share. Due to inadvertence, this conversion was not disclosed.

About LevelJump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its IHF's (Independent Healthcare Facilities). JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler
Chief Executive Officer

Caitlin-Robyn Densmore
Investor Relations Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
(437) 214-1568

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, considering the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.